FRIEDLI PETER [Rocket]

Date Filed	Type	Description
07/25/2018	SC 13D/A	FRIEDLI PETER reports a 42.9% stake in Osiris Therapeutics, Inc.
12/28/2012	SC 13D/A	FRIEDLI PETER reports a 44.9% stake in Osiris Therapeutics, Inc.
09/25/2008	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/31/2007	SC 13D/A	FRIEDLI PETER reports a 48.4% stake in Osiris Therapeutics, Inc.
09/27/2007	SC 13D/A	Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
06/13/2007	SC 13D/A	SEC Filing in the EDGAR database
12/20/2006	SC 13D	SEC Filing in the EDGAR database
11/02/2005	SC 13G/A	FRIEDLI PETER reports a 0% stake in
10/18/2005	SC 13G/A	FRIEDLI PETER reports a 0% stake in
09/27/2005	SC 13G/A	FRIEDLI PETER reports a 0% stake in
04/04/2005	SC 13D/A	FRIEDLI PETER reports a 0% stake in
04/07/2003	SC 13D/A	FRIEDLI PETER reports a 0% stake in
03/05/2003	SC 13G/A	FRIEDLI PETER reports a 0% stake in
02/06/2003	SC 13D	FRIEDLI PETER reports a 0% stake in
04/29/2002	SC 13G/A	FRIEDLI PETER reports a 0% stake in
02/14/2002	SC 13G/A	FRIEDLI PETER reports a 0% stake in
10/26/2001	SC 13G/A	FRIEDLI PETER reports a 0% stake in
05/21/2001	SC 13G	FRIEDLI PETER reports a 0% stake in
02/14/2001	SC 13G	FRIEDLI PETER reports a 0% stake in
02/08/2001	SC 13D	FRIEDLI PETER reports a 0% stake in
02/13/1997	SC 13D/A	FRIEDLI PETER reports a 0% stake in
10/22/1996	SC 13D	FRIEDLI PETER reports a 0% stake in